Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-24-000129

Chief Financial Officer sold 2,542 shares at $49.03 ($124,634)

  • Chief Financial Officer acquired 7,473 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Jones Cecilia · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-09-26 Exercise or conversion : show line 1 in the form 10b5-1 +7,473 22,700 D
2024-09-26 Sale : show line 2 in the form 10b5-1 −2,542 $49.03 $124,634 20,158 D
Open-market sales · 2,542 sh · avg $49.03 · $124,634

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-09-26 Exercise or conversion : show line 3 in the form 10b5-1 Restricted stock units −7,473 7,472 D
Loading xslF345X05/wk-form4_1727727323.xml…